PA1b inhibitor binding to subunits c and e of the vacuolar ATPase reveals Its insecticidal mechanism by Muench, SP et al.
	



	
	
	
	

		
	

	
				


 !∀#!
!∀!∃%!&!∋(!)∗!∋∀!#!#!+!!,!
−
! )!.	!∗−! /01234#)255	
56	
5	

	
)#7		((,

8

6+(	%!
09/04299:2317∀∀;1102:90<
		=

62121>3?5 22<320<1


		

	

	≅	

				

PA1b Inhibitor Binding to Subunits c and e of the Vacuolar
ATPase Reveals Its Insecticidal Mechanism*□S
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Background: Pea albumin 1b (PA1b) is a potent and selective inhibitor of insect vacuolar ATPase, but its mechanism is
poorly understood.
Results: PA1b binds the extracellular surface of the c ring and contacts subunit e.
Conclusion: PA1b inhibits V-ATPase by blocking transition of its rotor past subunit e.
Significance: This reveals insights into the mechanics and mode of inhibition of the V-ATPase.
The vacuolar ATPase (V-ATPase) is a 1MDa transmembrane
proton pump that operates via a rotary mechanism fuelled by
ATP. Essential for eukaryotic cell homeostasis, it plays central
roles in bone remodeling and tumor invasiveness, making it a
key therapeutic target. Its importance in arthropod physiology
also makes it a promising pesticide target. The major challenge
in designing lead compounds against the V-ATPase is its ubiq-
uitous nature, such that any therapeutic must be capable of tar-
geting particular isoforms. Here, we have characterized the
binding site on the V-ATPase of pea albumin 1b (PA1b), a small
cystine knot protein that shows exquisitely selective inhibition
of insect V-ATPases. Electron microscopy shows that PA1b
binding occurs across a range of equivalent sites on the c ring of
themembrane domain. In the presence ofMgATP, PA1b local-
izes to a single site, distant from subunit a,which is predicted to
be the interface for other inhibitors. Photoaffinity labeling stud-
ies show radiolabeling of subunits c and e. In addition, weevil
resistance to PA1b is correlated with bafilomycin resistance,
caused bymutation of subunit c. The data indicate a binding site
to which both subunits c and e contribute and inhibition that
involves locking the c ring rotor to a static subunit e and not
subunit a. This has implications for understanding the V-
ATPase mechanism and that of inhibitors with therapeutic or
pesticidal potential. It also provides the first evidence for the
position of subunit e within the complex.
The vacuolar H-ATPase (V-ATPase)4 is a complex molec-
ular machine responsible for the transmembrane movement of
protons against a gradient, fuelled byATP. It plays a central role
in the physiology of virtually all eukaryotic cells, performing
such critical functions as acidification of endosomal compart-
ments and energization of secondary active transport (1, 2). The
importance of the V-ATPase is also highlighted by the roles it
plays in human diseases, such as renal tubular acidosis, inher-
ited forms of deafness, osteopetrosis, autophagic myopathy,
pulmonary tuberculosis, and tumor cell survival and invasion
(3–6). The V-ATPase has bi-domain architecture similar to
that of the F-ATPase (ATP synthase) of mitochondria, consist-
ing of a rotarymotormechanically coupled to a transmembrane
proton pump (7, 8). The V-ATPase is, however, substantially
larger and more complex, with several unique subunits pro-
posed to be involved in its regulation (1, 9).
Eukaryotic V-ATPase contains at least 29 polypeptides of 13
types. These forma solubleV1domain that hydrolyzesATP and
a Vo membrane domain that pumps protons. V1 contains sub-
units A–H with stoichiometry A3B3CDEF3G3H, with the
ATPase motor consisting of an A3B3 pseudo-hexamer (10, 11)
(Fig. 1A). Vo is smaller and has subunits a, d, and e and a deca-
meric ring of c subunits. Subunits C–H form a network of stalks
linking Vo to the AB hexamer in V1 that function as a stator
holding the transmembrane a subunit fixed relative to theD–F-
d-c ring rotor, with this interaction driving proton transloca-
tion via a process that remains to be fully resolved.
The roles that the V-ATPases play in bone demineralization
and tumor cell survival have made it an important therapeutic
target (12, 13). A number of potent inhibitors have been shown
to bind tightly to the c ring (14–16), presumably preventing
proton translocation by obstructing procession of the rotor
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through the a subunit interface. The ubiquity of the V-ATPase
has made drug development challenging, but a potential solu-
tion is to target different subunit isoforms that are particularly
highly expressed in certain cell types. However, a lack of high
resolution structural information detailing isoform differences
has limited design of targeted inhibitors.
The insecticidal plant toxin pea albumin 1 subunit b (PA1b)
has been isolated from pea seeds (17–19) and its structure
solved (20). This revealed a cystine knot fold with three disul-
fide bridges and a high degree of stability (Fig. 1,B andC). PA1b
is one of the few orally active entomotoxin peptides currently
known and has been shown to be a selective insecticide, acting
on numerous agricultural pests and displaying a high toxicity
for mosquitoes (17, 19). It has attractive industrial attributes,
being extracted from a common agricultural crop (Pisum sati-
vum), consumed by humans and other mammals without any
reports of toxicity or allergenicity and is suitable for production
in transgenic plants. Thus, PA1b could be an attractive alterna-
tive to chemical pesticides and could even qualify for use in
organic farming. In the rice weevil (Sitophilus oryzae) there are
strains totally resistant to PA1b (21, 22), hence development of
resistance is a potential problem. PA1b has been shown to
interact with the Vo domain of V-ATPase (23). However, the
subunit(s) towhich it binds are not known.The basis for its high
degree of selectivity and ability to inhibit the V-ATPase from
the extracellular environment of the insect gut remain unclear.
Current models of inhibition by other compounds, such as
themacrolide bafilomycin, suggest that it is not binding to sub-
unit c (or a) per se that inhibits the enzyme. Rather, inhibition is
only expressed when the c ring rotates to bring the inhibitor-
bound c subunit into contact with subunit a, hence the appar-
ent additional role for this subunit in bafilomycin (24) and api-
cularen (14) binding. A corollary of this model is that in the
presence of MgATP, the inhibitor should be localized at (or
close to) the c ring/a interface. Here we report characterization
of PA1b binding to the V-ATPase of the agricultural pest
tobacco hornworm (Manduca sexta) using structural and bio-
chemical techniques. Using electron microscopy, we show that
PA1b binds at the base of the c ring, the first direct visualization
of inhibitor binding to V-ATPase. In contrast to predictions of
existing models, addition of ATP to induce stepping of the
V-ATPase rotor failed to localize PA1b into the subunit a/c ring
interface. Instead, biochemical and electron microscopy data
indicate that PA1b binds at a site to which both the e subunit
and c ring contribute. This site has some overlap with that for
bafilomycin. These results offer new insights into both the
structural arrangement of the V-ATPase and characterization
of a highly specific inhibitor with pesticidal potential.
EXPERIMENTAL PROCEDURES
Insect Rearing and Bioassays—S. oryzae strains WAA42 and
ISOR3 were reared according to Louis et al. (25). Toxicity
assays with PA1b or bafilomycin were conducted as described
previously (15). PA1b labeling using 125I and binding assays
using the 125I toxin were performed according to Ref. 22, and
binding data were analyzed using the SIMFIT software. Fifth
instar larvae of M. sexta (Lepidoptera, Sphingidae), weighing
6–8 g, were reared under long day conditions (16 h of light) at
27 °C using the gypsy moth diet (MP Biomedicals). The M.
sextaV1Vo holoenzymewas extracted and purified as described
previously (15), which displayed clear and discrete bands on
SDS-PAGE (see Fig. 4A).
PA1b Extraction and Synthesis—Native PA1b was extracted
from pea seeds with solvent extraction and HPLC purification.
FIGURE 1. Organization of the V-ATPase and structure of PA1b. A, the reconstruction of the M. sexta V-ATPase from cryo-EM data (11) with crystal structures
of homologous subunits fitted and labeled. B, primary structure of the insecticidal peptide PA1b. Lines indicates the connectivity of the disulfide bridges. C,
three-dimensional structure of PA1b (Protein Data Bank ID code 1P8B) (20) showing -helical (red), -sheet (yellow), and random coil (green regions). Disulfides
are colored cyan.
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Briefly, pea seeds were ground and the flour dissolved in etha-
nol 60% (10 ml/g of flour) and incubated under stirring at 4 °C
for 2 h. The mixture was then centrifuged at 10,000  g for 10
min and the supernatant dried under vacuum. The resulting
powder was resuspended in ethanol (60%) and injected into a
reverse phase C18 HPLC column (250  4.6 mm, 5 m (Phe-
nomenex), on anAgilent 1200HPLC) eluted at 1mlmin1. The
gradient contained water (with 0.1% TFA)/acetonitrile (with
0.1% TFA) in the ratio 80/20 for 2 min, then 40/60 for 20 min.
PA1b peptide isoformswere detected by absorbance at 210 nm,
quantified by themeasurement of peak areawithweighted pure
peptide as standards.
The benzophenone moiety was introduced at position 12 to
Fmoc-4-benzoyl-L-phenylalanine (Fmoc-L-Bpa), a position
shown to not be essential for PA1b binding (26). The variant
was synthesized and folded following the optimized procedure
described for the production of synthetic PA1b (27), using
solid-phase peptide methods and the Fmoc/tBu (N-(9-fluore-
nyl)methoxycarbonyl/tertbutyl) strategy (24, 25). Purity of the
peptide was assessed using RP-HPLC and MALDI-TOF mass
spectrometry.
PA1b-biotin was obtained from Proteogenix (Strasbourg,
France) and was chemically synthesized with the biotin group
attached on the N terminus. PA1b-biotin was folded in vitro
according to Da Silva et al. (27).
PA1b Complex Formation—This was conducted using two
different protocols. In the first instance, biotinylated PA1b (1
mg ml1) was mixed with streptavidin-HRP ((Thermo Scien-
tific 21126) (5mgml1)) and preincubated overnight. A total of
6l of this conjugate wasmixedwith 4l of V-ATPase (1mg of
proteinml1) andmade up to 60l usingV-ATPase buffer (150
mMNaCl, 20mMTris-HCl, pH 8.1, 9.6mM 2-mercaptoethanol,
0.01% C12E10). For the second experiment, 4 l of V-ATPase (4
g) was mixed with 3 l of biotin-PA1b (3 g) and 3 l of
streptavidin-HRP (15 g), made up to 60 l using V-ATPase
buffer and incubated for 30 min. MgATP was from a stock
solution of 100 mM at pH 7.5 to a final concentration of 5 mM,
and the mixture was incubated at room temperature for 5 min
to allow for complete turnover.
Inhibitor Assays—V-ATPase assays based on the detection of
released phosphate using theM. sexta V-ATPase or yeast vac-
uolar membranes were carried out as reported previously (23,
28, 29).
Subunit c and e Substitutions—Total RNA was extracted
from80mgof S. oryzae using the RNAspinmini kit (GEHealth-
care), and cDNA was obtained with the Moloney murine leu-
kemia virus reverse transcriptase (NewEnglandBiolabs). The S.
orizaeV-ATPase subunits e and c cDNAwere obtained by PCR
using primers designed according to the sequences found in
S. orizae sensible strain WAA42 EST (30). The primer pairs
were 5-CTCGAGTTAGTTCAGTGGATTACCCCATGC-3
(forward)/5 GGATCCATGGGTGCAGCAGCTTTGCCTT-
TTAT-3 (reverse) and 5-AACATGGGGGTGGGAAT-
TGT-3 (forward)/5-TCAGTGCTGTGTTGTGCACCT-3
(reverse), respectively. The e and c cDNA were inserted in the
yeast expression vector pYES2 (Invitrogen) between the XhoI
and BamHI restriction sites. Plasmids carrying the coding se-
quence for S. orizae V-ATPase subunits e or c were used to
transform by electroporation Saccharomyces cerevisiae strains
based on strain BY474 (Mat a, his31, leu20; met150, ura-
30) that were, respectively, deleted for YCL005w-A
(VMA9::kanMX4) or YEL027w (VMA3::kanMX4), obtained
from Euroscarf (Frankfurt, Germany). For expression of the
heterologous gene, yeast were grown on selective galactose
medium (0.7%w/v YNB, 2%w/v galactose, 2% w/v agar, 0.002%
w/v histidine, 0.006%w/v leucine, and 0.006%w/vmethionine).
The analysis of pH dependence of growth was carry as de-
scribed in (31). PA1b was added onto the medium to test the
effect of toxicity at 1 mg ml1.
Photoaffinity Labeling—For labeling,M. sexta V1Vo holoen-
zyme (30 g), V1 complex (20 g), or Vo complex (10 g) in 80
l of V-ATPase buffer were mixed with 1 l 125I-PA1b-benzo-
phenone (10 kilobecquerels l1 determined by scintillation
counting) and incubated for 5 min at 20 °C. Cross-linking was
induced by irradiating the samples for 10 min with UV light on
ice. Subsequently, samples were separated by SDS-PAGE and
stainedwith Coomassie. The gels were then dried onWhatman
paper, exposed to a phosphorimaging screen, and analyzedwith
a PhosphorImager (GE Healthcare). Afterward the lanes of the
dried gel were cut into approximately equally sized slices,
including regions where no Coomassie-stained proteins were
visible. Each piece was mixed with 5 ml of scintillation liquid,
and the disintegrations were counted (Beckman LS6500 scin-
tillation counter) up to 10,000 counts for each sample to ensure
a S.D. of 1%.
Electron Microscopy—Negative stain grids were prepared by
applying 3 l of protein solution (40 gml1) onto a carbon-
coated copper grid that had previously been placed for 40 min
under a UV lamp (32). The grid was then stained with 1% w/v
uranyl acetate. Grids were imaged using a Technai T12 micro-
scope fitted with a LaB6 source operating at 120 kV. Micro-
graphs were recorded on a 2000 2000 Gatan CCD camera.
Particles were hand-picked using the Boxer program in
EMAN2 (33). Particles were centered, masked, and classified in
IMAGIC-5, resulting in a crude set of reference images, which
were used for multireference alignment (34). The classes pro-
duced were significantly improved, and representative ones
were used for a further stage of multireference alignment. This
process was iterated until no further improvement was observed.
Poorly aligning particles were removed.
Three-dimensional reconstructions were generated in
EMAN using the previously solved intact M. sexta V-ATPase
reconstruction filtered to 50 Å as an initial starting model. The
resulting three-dimensional reconstruction showed clear dif-
ferences to the starting model at the base of Vo. An additional
model of the negatively stained M. sexta V-ATPase was also
generated as a control to ensure that the features seen were not
artifacts of staining. Because only 20% of the V-ATPase par-
ticles showed binding, models were generated using in the first
instance those particles which showed a clear PA1b/streptavi-
din-HRP density, along with representative particles of the
V-ATPase in orientations forwhich the PA1bwas not visible. In
a second experiment, these models were used for multimodel
refinement using both an apparent PA1b-bound model and an
unbound model, both filtered to 50 Å. Unsupervised multi-
model refinement was carried out on the full data sets in both
Characterization of PA1b Binding
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EMAN multimodel mode and Xmipp ML3D classification
mode to check that selection of particles was not biasing the
resulting models (35, 36). The resulting independently gener-
ated reconstructionswere of equivalent quality and showed fea-
tures consistent with PA1b binding.
RESULTS
Benzophenone and Biotin Derivatives of PA1b Remain Effec-
tive V-ATPase Inhibitors—Two PA1b derivatives were used for
this study. These were substituted either by a benzophenone
photoactivable group or by a biotin group. Measurement ofM.
sexta V-ATPase activity in the presence of the PA1b-biotin
derivative showed no significant difference in activity from
native PA1b (Fig. 2A). Competitive inhibition of 125I-PA1b
binding to a S. oryzaemembrane extract by the modified PA1b
revealed no significant difference in the binding of PA1b, PA1b-
benzophenone or PA1b-biotin (Ki of 6.5  1.13 nM, 11  2.2
nM, and 5.4  6.6 nM, respectively (Fig. 2B)).
Identifying the PA1b Binding Site by Electron Microscopy—
Negative stain grids showed theV-ATPase to bemonodisperse,
with little dissociation of the complex. Image class averages
were well defined and showed clear stator connections. To
reduce any bias in data processing, in the first instance six sam-
ples were prepared: 1, V-ATPase; 2, V-ATPase with streptavi-
din-HRP; 3, V-ATPase with 5% ethanol (control for the PA1b
solvent); 4, V-ATPase with biotin-PA1b; 5, V-ATPase with
simultaneously added biotin-PA1b and streptavidin-HRP and
6, V-ATPasewith biotin-PA1b/streptavidin-HRP complex pre-
formed by overnight conjugation. The electron microscopy
data were then collected at 23,000 magnification and pro-
cessed blind to minimize bias. In total, 8644, 8543, 6538, 8006,
9712, and 5740 particles were picked using EMAN2 for samples
1, 2, 3, 4, 5, and 6, respectively. The resulting classes showed
that only two samples displayed extra density about the base of
Vo (supplemental Fig. 1). These samples were the only ones to
contain the full PA1b streptavidin-HRP complex, with no nota-
ble differences being detected with preformed complex or
simultaneous addition of the label components (samples 5 and
6). Analysis of the data showed that 20% of V-ATPase parti-
cles were labeled. To improve resolution, data were collected at
30,000magnification, giving 10,056 particles from527micro-
graphs. Additional grids were prepared for V-ATPase with
MgATP with data also collected at 30,000 magnification,
with 841 micrographs providing 11,341 particles. Particles that
aligned poorly, that were unstable during classification or pro-
duced obviously degraded or nonrepresentative views were
removed, resulting in 6720 and 7355 particles for the inactive
and ATP-treated specimens, respectively. Both datasets gave
distinctive classes in which PA1b binding could clearly be iden-
tified at the base of Vo (Fig. 3, A and B).
To further characterize the PA1b binding site, three-dimen-
sional reconstructions were generated for PA1b-labeled V-
ATPase  MgATP and compared with a control without
inhibitor (Fig. 3, C–E). In the absence of ATP, the resulting
reconstruction showed extra density distributed in a 115° arc
around the base of Vo (Fig. 3C), starting near stator filaments 2
and 3 which flank subunit c (11). The most plausible interpre-
tation of this labeling pattern is that binding occurs toward the
extracellular surface of the c ring. Based on the organization of
the homologous decameric NtpK ring (37), this could be in the
region of the C-terminal ends of transmembrane helices 2 or 4
of the subunit c four-helical bundle, or in the extracellular loop
linking helices 2 and 3. The distribution of label suggests that
labeling occurred at any one of 3–4 equivalent (and adjacent)
sites on the c ring. Strikingly, after addition of MgATP, the
density was restricted to an arc of only 30° (Fig. 3D), suggest-
ing that binding was limited to only a single subunit c site.
Although the reconstructions are of modest resolution and
quality, it is clear fromboth the classes and reconstructions that
in both the absence and presence of ATP, PA1b binding is dis-
tant from the a subunit/c ring interface, the proposed site of
inhibitor action for other molecules targeting the V-ATPase
membrane domain (14, 24). Models produced by EMAN and
FIGURE 2. Activities of modified PA1b. A, inhibition of the ATPase activity of M. sexta V-ATPase by PA1b and PA1b-biotin. B, competitive binding of 125I-PA1b
(0.4 nM) at increasing concentrations of PA1b (filled circles), chemically synthesized PA1b-biotin (open circles), or benzophenone-PA1b (filled triangles). Binding
was to a crude membrane extract of S. oryzae. The nonspecific binding was determined by adding a large amount of purified PA1b (1 M) and was 25–35% of
total binding.
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Xmipp were consistent, both in single-model refinement mode
and after unsupervised multimodel refinement.
PA1b Binding to the e and c Subunits—Independent confir-
mation of the binding of PA1b to subunits at the base of Vowas
provided by photoaffinity labeling with the 125I-labeled benzo-
phenone derivative of PA1b. After UV irradiation, covalent
attachment of the modified inhibitor to purified V1Vo holoen-
zyme or the separated Vo or V1 domains from M. sexta was
detected after SDS-PAGE by autoradiography of the dried gel.
In the gel system used, all subunits of the holoenzyme were
resolved (Fig. 4A, left), and their positions were identified by
immunoblotting (Fig. 4A, right). Note that subunits d and e
stain only weakly with Coomassie Blue (Fig. 4A, lane 2) but can
be located after staining with silver (Fig. 4A, lane 1). The auto-
radiography showed UV irradiation-dependent labeling of
three species (identified as L1–L3 in Fig. 4B, right) in both the
holoenzyme and in Vo, but not in the soluble catalytic domain
V1. To confirm localization of radioactivity to these regions of
the gel, the dried gel was cut into slices as indicated in Fig. 4B
and disintegrations of the slices determined by scintillation
counting (Fig. 4C). The applied 10 kilobecquerels was almost
completely recovered, and as expected, the majority of the
radioactivity was in slice 3 (data not shown) which is just above
the dye front after electrophoresis. The next most radioactive
slices were numbers 7 and 8, reflecting the approximate posi-
tion of the Vo subunit e, as indicated by silver staining and
immunoblotting of the comparable nonradioactive sample
(Fig. 4A).
To determine the masses of the 125I-PA1b-labeled species, a
calibration curve of molecular mass versus relative migration
on SDS-PAGE was constructed (Fig. 4D). Masses of V-ATPase
subunits were determined from their primary structures (with
the exception of the e subunit that has an actualmass of 9.7 kDa
but apparent mass of 20 kDa because of extensive glycosylation
(49)). Masses of radiolabeled species L1, L2, and L3 were deter-
mined to be 27.5, 21.6, and 18.4 kDa, respectively. Given that
labeling occurs exclusively at the Vo membrane domain con-
taining only a, c, d, and e subunits, the radioactively labeled
band L3 can be identified as subunit c (mass of 15.8 kDa) with a
PA1b adduct adding an apparent additional mass of 2.5 kDa.
Similarly, band L2 is most likely to be subunit e (mass 	20 kDa
with a 1.6-kDaPA1b adduct. BandL1 can be assigned as a dimer
of subunit c; although the deduced mass of 27.5 kDa (including
a PA1b adduct) is significantly less than double the mass of
subunit c, dimers of this type of polypeptide have been observed
to migrate anomalously quickly during SDS-PAGE (38). The
ratio of intensity of bands L2 and L3 reflects the likely 10:1 c:e
stoichiometry.
Expression of Insect c or e Subunit in Saccharomyces Is Not
Sufficient to Confer Sensitivity to PA1b—If insect c and e sub-
units constitute the binding site for PA1b, it could be predicted
that heterologous expression of these polypeptides in a suitable
host might confer sensitivity of the host V-ATPase to PA1b.
Expression ofM. sexta subunit c in a S. cerevisiae strain deleted
for theVMA3 gene encodingM. sexta subunit c (14) did lead to
complementation of the pH-sensitive conditional lethal pheno-
type characteristic of vmamutants (39) indicated by growth of
transformed cells at pH 7.5, and hence the insect c subunitmust
be incorporated into a functional V-ATPase. However,
although the M. sexta V-ATPase is inhibited by PA1b with an
apparentKiof91nM (Fig. 5), expression of the insect c subunit
did not confer PA1b sensitivity to yeast (Fig. 5). Wild type and
M. sexta c-expressing yeast strains both produced V-ATPase
activity that was equally sensitive to bafilomycin (Ki 2.4 nM).
Similarly, although the S. oryzae c subunit complemented the
vma3mutation, resulting inwild type levels of growth at pH7.5,
transformed cells were not sensitive to PA1b (data not shown).
Growth of the e subunit mutant on pH 7.5 medium showed no
difference between the mutant and wild type. However, exper-
iments using 125I-PA1b showed no binding activity on mem-
brane extracts from transformed yeast expressing either c or e
subunit from S. oryzae.
PA1b-resistant S. oryzae Are Partially Resistant to Bafilomycin—
Assays of in vivo sensitivity to bafilomycin of two cereal weevil
strains were performed by adding the inhibitor to the food sup-
FIGURE 3. Electron microscopy of PA1b-bound V-ATPase. A, representa-
tive classes of PA1b-streptavidin-HRP-bound V-ATPase in the absence of ATP.
B, as A but in the presence of 2 mM MgATP. The PA1b-streptavidin-HRP den-
sity is indicated by an arrow in the far left panel 1 of A. Scale bars in both A and
B represent 15 nm. C–E, three-dimensional reconstructions of the V-ATPase
viewed perpendicular to the long axis of the complex (upper image) and from
the extracellular end (lower image) bound to PA1b (C), bound to PA1b after
the addition of MgATP (D) and a control with no PA1b (E). All models were
generated using EMAN, and the picture was produced using Chimera ren-
dered at the same sigma level. In C (lower), the decameric c ring (Protein Data
Bank ID code 2DB4 (53) rainbow colors) and a subunit model (red) have been
fitted to the PA1b-streptavidin-HRP V-ATPase reconstruction in the absence
of ATP using Chimera. If catalytically active, the c ring would rotate counter-
clockwise with respect to subunit a when observed from this perspective.
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ply. Animals of PA1b-sensitive strain WAA42 were also sensi-
tive to bafilomycin at 0.36 and 0.60 mg/g of food, with deduced
TL50 of 12.6  2.3 and 9.4  1 days, respectively (Fig. 6). In
contrast, no mortality was observed with the PA1b-resistant
strain ISOR3 at these doses. Only at a dose of 2.0 mg/g food
were the PA1b-resistant weevils killed by bafilomycin, but with
aTL50 of 9.9 0.5 days for ISOR3 animals comparedwith 4.0
0.2 days for WAA42. Moreover, even up to 10 M bafilomycin
was unable to inhibit binding of radiolabeled PA1b to WAA42
membrane extracts (data not shown).
DISCUSSION
The V-ATPase is an important therapeutic target principally
because of its roles in cancer cell survival and bone resorption
(40, 41). Because tumor cell V-ATPase is essential for regula-
tion of cytoplasmic pH and acidification of the extracellular
environment, V-ATPase inhibitors induce apoptosis and loss of
invasive phenotype (41). Inhibition of activity in osteoclasts
decreases bone resorption, hence inhibitors have also been
assessed at length as anti-osteoporotic drugs (13). The central
role of the V-ATPase in insect gut physiology (42) means that
the enzyme is also valuable as a potentially novel pesticide (43).
There is also potential for development of anti-malarials target-
ing the Plasmodium parasite (44, 45) or its mosquito vector
(46). Development of lead compounds should be achievable
through targeting isoforms highly expressed in particular cells
or tissues, such as the a3 isoform in osteoclasts. However,
FIGURE 4. Characterization of PA1b binding. A, left, SDS-PAGE analysis of purified M. sexta V-ATPase with staining with silver (lane 1) or Coomassie Brilliant
Blue (lane 2) and M indicating molecular mass markers. Right, identification of the staining polypeptides by immunoblot analysis. B, photoaffinity labeling of M.
sexta V-ATPase with the 125I-PA1b-benzophenone. For labeling, V1Vo holoenzyme (V1Vo), Vo complex (Vo), or V1 complex (V1) was incubated with
125I-PA1b-
benzophenone and exposed to UV light or kept in the dark. After separation by SDS-PAGE, the stained and dried gel was exposed to a phosphorimaging screen.
Left, SDS-PAGE of the V-ATPase complexes with Coomassie Blue staining. Right, readout of the phosphorimaging screen for labeled holoenzyme (lanes 1–3), Vo
(lanes 4 – 6), and V1 (lanes 7–9) after either UV irradiation (U) or maintenance in the dark (D). Bands L1–L3 (arrows) indicate UV-dependent labeled species. C,
slices of the dried gel from samples of the V1VO holoenzyme (open circles) and Vo (filled circles) subjected to scintillation counting. The column to the left of B
indicates positions of gel slices subjected to counting. The majority of the radioactivity was found in slice 3 near the dye front. D, molecular mass determination
of 125I-labeled V-ATPase subunits. A calibration curve was prepared by plotting log molecular masses of standard proteins (triangles, dashed line) and V-ATPase
subunits (deduced from their primary structure) against their relative migration on the SDS-polyacrylamide gels shown in A (open circles, dotted line) and B (filled
circles, solid line). In each case, linear regression gave r2
0.99.
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although some selectivity has been reported (47), the ubiqui-
tous nature of theV-ATPase has limited identification of highly
selective inhibitors. The peptidic inhibitor PA1b is therefore
remarkable, not only because of its V-ATPase specificity and
potency, but also because it is uniquely selective against the
enzyme from insects (17, 19). To date, the precise interaction of
PA1b with the V-ATPase has remained unexplained. The data
presented here provide a much clearer picture of binding and
hence themechanism of inhibition, opening the door to further
development.
Previous work has shown that PA1b binds to Vo which con-
sists only of subunits a, d, e and the c ring (23). Although this
implies an effect on proton translocation, assignment of bind-
ing to a particular subunit could not be made. Consequently,
conclusions about the mode of PA1b action were also limited.
In this work, novel use of a streptavidin-HRP tag has allowed
visualization of PA1b binding to the V-ATPase by electron
microscopy. PA1b at 3.7 kDa is too small to visualize directly at
the level of resolution attainable by negative stain electron
microscopy. Visualization was instead made by attaching a
streptavidin-HRP tag to biotinylated PA1b that is readily
detected in the electronmicroscope. Crucially, the biotin linker
is sufficiently short and the tag structure sufficiently compact
that the streptavidin-HRP density provides an accurate indica-
tor of the site of PA1b binding.
Classes and reconstructions both clearly show PA1b binding
to the base of Vo, a surface that is extracellular to the plasma
membrane of theManducamidgut. Only four polypeptides are
recognized components of Vo (with likely stoichiometry a:c10:
d:e). The data presented here exclude binding to d, the 40-
kDa subunit that couples the axle of the V-ATPase rotor to the
c ring on the cytoplasmic side of the membrane (48). The data
also appear to exclude binding to subunit a, the membrane
subunit that forms the asymmetric mass within Vo. Binding to
the c ring or to e can therefore be inferred, and contact with
both is in fact supported by photochemical labeling data. These
show Vo components of masses approximating only to those of
c and e shifted on SDS-PAGE, by the attached inhibitor. The
apparent masses of PA1b adducts required to be added to sub-
units c and e to give the radiolabeled bands 2 and 3 in Fig. 4 are
neither equal in both cases nor equivalent to the actual mass of
PA1b (3.7 kDa). However, this is not unexpected because a shift
in migration on SDS-polyacrylamide gel rarely reflects the sim-
ple sumof themasses of adduct and target polypeptide. Instead,
migration will likely be influenced by both the position of the
cross-linking adduct and its impact on the chemical character
of the target polypeptide. In this respect, it is worth noting that
both c and e migrate anomalously because they are highly
hydrophobic and extensively glycosylated, respectively.
Based on the crystal structure of the homologous NtpK ring,
M. sexta subunit c is modeled as a four-transmembrane helix
bundle, with both its N and C termini on the luminal/extracel-
lular side of the membrane (29). Assembled as a ring of 6–10
subunits, helices 1 and 3 alternate to form an inner ring with
helices 2 and 4 forming an outer ring in contact with the lipid
phase. Based on this model and the available electron micros-
copy data, the regions of subunit c to which PA1b most likely
binds are the extreme N and C termini and the extracellular
loop linking helices 2 and 3. These regions do not appear to
make contact with other subunits, hence their sequences are
least conserved in the otherwise generally highly conserved
polypeptide. This variability may explain the remarkable selec-
tivity of PA1b for the insect protein.
The position of subunit e in Vo is much less certain. This
88-residue polypeptide is predicted to fold with two transmem-
brane helices and carries extensiveN-linked glycosylation (49).
A consensus glycosylation site is present toward its C terminus
(Asn-68), implying that both termini could be on the luminal/
extracellular side of the membrane. Presumed to be part of the
stator in association with subunit a, its assembly into the rotor
of the complex has not been excluded. The data presented here
indicate that subunits e and c must be in close proximity
FIGURE 5. Inhibition of yeast V-ATPase activity. V-ATPase activity from the
wild type S. cerevisiae strain BMA64-1B (WT) and BMA64-1B deleted for the
VMA3 gene but expressing the M. sexta c subunit was measured in the pres-
ence of bafilomycin A1 (open circles) and PA1b (filled circles). For comparison,
inhibition of the purified V1Vo holoenzyme of M. sexta (squares) by PA1b is
included.
FIGURE 6. Toxicity of the V-ATPase inhibitor bafilomycin toward PA1b-
resistant S. oryzae. 30 rice weevils (S. oryzae) were fed on artificial diet incor-
porating each tested compound over 14 days. The weevil strains were WAA42
(PA1b-sensitive strain: open symbols) and ISOR3 (PA1b-resistant strain: filled
symbols). Bafilomycin was included in food at 0.36 (squares), 0.60 (circles), or
2.00 mg/g food and survival over a 14-day period monitored. Open diamonds/
dashed line, control for artificial diet with bafilomycin solvent.
Characterization of PA1b Binding
JUNE 6, 2014 • VOLUME 289 • NUMBER 23 JOURNAL OF BIOLOGICAL CHEMISTRY 16405
 at U
N
IV
ERSITY
 O
F LEED
S on M
arch 26, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
because both are labeled by PA1b, and two separate binding
sites on completely different polypeptides seem unlikely. The
e/c contact could be either static, with both subunits forming
parts of the rotor, or via a stator-rotor interface that is dynamic
during catalysis. To further clarify binding, we introduced
PA1b-sensitive insect c and e subunit into yeast strains dis-
rupted for the corresponding homologues. Parent strains of
these yeasts are insensitive to PA1b (23). In both cases, although
the insect proteins complemented the pH-sensitive condition-
ally lethal phenotype of the deletion strains (restoring bafilomy-
cin-sensitive activity), there was no detectable increase in sen-
sitivity to PA1b. These data indicate that neither the e or c
subunit alone is sufficient to form the PA1b binding site, sug-
gesting that both subunits are required. Unfortunately, a
VMA3/VMA9 double knock-out yeast strain could not be pro-
duced to test this further.
Lipophilic molecules such as bafilomycin, archazolid, and
apicularen bind to the lipid-exposed surface of subunit c (14, 15,
29). The additional role of subunit a in the inhibitory effects of
bafilomycin and apicularen (14, 24) implies that the inhibitor
links c to a at the rotor-stator interface, obstructing stepping of
the rotor and preventing proton translocation. A prediction of
this model is that for a c ring carrying a single inhibitor mole-
cule, rotation energized by the catalytic cycle of the enzyme
should propel the inhibitor-loaded c subunit to the stator inter-
face, allowing it to contact subunit a. Thus, in the presence of
ATP, inhibitor should localize to a point adjacent to the stator.
Using the image averaging method applied here, this would
equate to PA1b no longer appearing to be distributed about
multiple equivalent positions, with the mass instead becoming
focused at a single location. This prediction was partly substan-
tiated, with bound PA1b apparently becoming restricted to a
single c subunit when it was present during catalytic activity.
However, its location distant from the asymmetric density that
represents subunit a in the classeswas surprising, clearly incon-
sistent with the models of inhibitor action outlined above. This
leads to a number of possibilities. First, the inhibition model is
correct, but the membrane-bound part of the V-ATPase stator
extends significantly further around the c ring than previously
suspected, such that the inhibitor label seen in Fig. 4D is actu-
ally bound to the c ring/stator interface. Subunit e could be part
of this interface, explaining its photochemical labeling. How-
ever, based on the expected direction of c ring rotation (coun-
terclockwise in Fig. 4, C and D), the inhibitor label in Fig. 4D
would be closest to the point at which the rotating c ring exits
the interface with subunit a, not enters it. To accommodate
this, PA1bwould have to prevent the c ring from stepping out of
its interface with the stator rather than obstructing its entry. A
second possibility is that PA1b binds only to c subunits that
have a particular conformation affected by the catalytic cycle of
the enzyme. This is speculative, but conformational variability
could also explain why PA1b binds only a discrete number of
adjacent c subunits to one side of the c ring. It is clear from
electronmicroscopy that not all potential sites on the c ring are
occupied by PA1b even at high inhibitor/enzyme ratios. This
suggests that characteristics of individual c ring subunits could
vary according to their position with respect to subunit a.
An unexpected result was obtained when the sensitivity to
bafilomycin of PA1b-resistant cereal weevil strains was exam-
ined. There is clear correlation between resistance in vivo to
PA1b and bafilomycin, implying significant overlap in their
binding sites. However, PA1b bindingwas not inhibited by bafi-
lomycin even at concentrations 10,000-fold higher than its
IC50. Our electron microscopy data indicate that PA1b exerts
its effect away from subunita, whereas bafilomycin is presumed
to act at the a/c subunit interface. Therefore we presume that
the common element for bafilomycin and PA1b toxicity is the c
subunit. It has been shown previously that PA1b binds with
high affinity to extracts from susceptible S. oryzae but that there
is no detectable binding to equivalent extracts from resistant
weevils (22). Consequently, resistance is due to modification of
the PA1b-binding protein rather than for example, enhanced
catabolism of inhibitor. Sequences of S. oryzae subunit c show
only two amino acid changes in four PA1b-resistant strains that
have been examined: Ser-83 in the extracellular loop between
helices 2 and 3 is replaced by Asn, and Ala-159 at the extracel-
lular C-terminal end of helix 4 is replaced by Thr. In models of
subunit c these residues are in close proximity and in the region
identified as PA1b binding by the electron microscopy data.
Notably, e subunits are identical in susceptible and resistant
animals.5 Bafilomycin and PA1b may have a close but different
binding site on the c subunit, such that bafilomycin does not
directly compete with 125I-PA1b. However, the sequence
change between the PA1b-sensitive and -resistant weevils can
be sufficient to exert a relatively long range effect on the bafilo-
mycin binding site. In this regard, mutations to fungal c sub-
units that correlate with bafilomycin resistance include
changes to residues that are some distance from the proposed
binding site or at locations within the packed helical bundle
(50). Hence, relatively long range or indirect effects on helical
packing can impact on bafilomycin binding. Investigations are
underway to understand increased resistance.
PA1b has activity against a number of pests, including cereal
weevils and mosquitoes, but to date it appears to be exclusively
insecticidal (17, 19). Sensitivity of insects to loss of V-ATPase
activity, using for example an oral RNAi approach (43, 51),
underline the potential of the complex as a potential target for
insecticides. Characterization of PA1b binding to insect V-
ATPase and explanation of its action will facilitate study of its
insecticidal potential. Inhibitors acting on the membrane
domains of the V- and F-ATPases may be unique in acting to
obstruct the rotary motion on which these enzymes depend.
Macrolide antibiotics such as bafilomycin are relatively lipid-
soluble (52); hence, they access Vo from the lipid phase and can
permeate into all membrane compartments in the cell. Binding
of PA1b to the surface of the V-ATPase rotor exposed on the
external surface of the cell gives it a further unique property, the
ability to inhibit without entering the cell. This property
explains how PA1b targets plasma membrane forms of the
V-ATPase and why the peptide is such a potent and effective
oral inhibitor.
PA1b has potential to be the leading compound of a new
insecticide class. Optimization of the interactions itmakes with
5 D. Pauron and F. Gressent, unpublished data.
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V-ATPase could help increase toxicity or even provide a tem-
plate from which to develop new insecticides. Thus, our study
has not only revealed important aspects of V-ATPase structure
and function, but can also inform development of novel inhib-
itors to treat a range of diseases.
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